A detailed history of Intellectus Partners, LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Intellectus Partners, LLC holds 545,533 shares of ABCL stock, worth $1.61 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
545,533
Previous 545,533 -0.0%
Holding current value
$1.61 Million
Previous $1.61 Million 12.52%
% of portfolio
0.37%
Previous 0.45%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$2.73 - $4.73 $10,237 - $17,737
3,750 Added 0.69%
545,533 $1.61 Million
Q1 2024

May 03, 2024

SELL
$4.29 - $5.97 $1.48 Million - $2.06 Million
-345,500 Reduced 38.94%
541,783 $2.45 Million
Q4 2023

Feb 05, 2024

BUY
$3.91 - $5.93 $41,641 - $63,154
10,650 Added 1.21%
887,283 $5.07 Million
Q3 2023

Oct 25, 2023

SELL
$4.6 - $7.95 $3,679 - $6,360
-800 Reduced 0.09%
876,633 $4.03 Million
Q2 2023

Jul 31, 2023

BUY
$5.66 - $7.59 $28,017 - $37,570
4,950 Added 0.57%
877,433 $5.67 Million
Q1 2023

May 04, 2023

BUY
$7.31 - $11.18 $28,509 - $43,602
3,900 Added 0.45%
872,483 $6.58 Million
Q4 2022

Feb 02, 2023

SELL
$9.48 - $14.52 $2.11 Million - $3.24 Million
-222,922 Reduced 20.42%
868,583 $8.8 Million
Q3 2022

Nov 14, 2022

BUY
$9.2 - $13.68 $16,099 - $23,940
1,750 Added 0.16%
1,091,505 $10.8 Million
Q2 2022

Aug 12, 2022

SELL
$5.72 - $10.65 $127,121 - $236,685
-22,224 Reduced 2.0%
1,089,755 $11.6 Million
Q1 2022

May 16, 2022

SELL
$7.46 - $14.14 $599,784 - $1.14 Million
-80,400 Reduced 6.74%
1,111,979 $10.8 Million
Q4 2021

Feb 14, 2022

SELL
$12.99 - $17.73 $403,339 - $550,516
-31,050 Reduced 2.54%
1,192,379 $17.1 Million
Q3 2021

Nov 16, 2021

BUY
$14.85 - $21.34 $244,282 - $351,043
16,450 Added 1.36%
1,223,429 $24.5 Million
Q2 2021

Aug 13, 2021

BUY
$20.19 - $34.17 $24.4 Million - $41.2 Million
1,206,979 New
1,206,979 $26.6 Million

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $841M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Intellectus Partners, LLC Portfolio

Follow Intellectus Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intellectus Partners, LLC with notifications on news.